Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
- Terminas
- 2027-09-16
- Atidaryta
- 2027-02-10
- Biudžetas
- 115 323 812 €
- Tipas
- grant
Aprašymas
Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:Patients afflicted by lung, bowel, breast or prostate cancer[1], will benefit from the outcomes of evidence-based, tailored, innovative, affordable and accessible diagnosis- and treatment-centred clinical research programmes by comprehensive cancer infrastructures[2].Researchers, physicians, patient representatives, civil society, charities, foundations, insurance companies, SMEs and innovators[3] will seize opportunities to respectively co-create, support, upscale or commercialise outcomes of evidence-based, tailored, affordable and accessible clinical research programmes for the diagnosis and treatment of patients afflicted by lung, bowel, breast or prostate cancer.National and regional healthcare providers, healthcare payers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to engage in piloting, upscaling or implementing appropriate clinical research programmes for the diagnosis and treatment of patients afflicted by lung, bowel, breast or prostate cancer.Scope:Lung, bowel, breast and prostate cancer incidence, mortality and prevalence across EU Member States and Associated Countries are increasing while showing substantial variation, with Central and Eastern European communities, regions and countries particularly affected[4]. At the same time
Tinkamumas (iš šaltinio)
General conditions1. Admissibility conditions: Proposal page limit and layoutdescribed in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.2. Eligible countriesdescribed in Annex B of the Work Programme General Annexes.A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.3. Other Eligibility Conditionsdescribed in Annex B of the Work Programme General Annexes.4. Financial and operational capacity and exclusiondescribed in Annex C of the Work Programme General Annexes.5a. Evaluation and award: Award criteria, scoring and thresholdsdescribed in Annex D of the Work Programme General Annexes.5b. Evaluation and award: Submission and evaluation processesThe thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12.described in Annex F of the Work Programme General Annexes and the Online Manual.5c. Evaluation and award: Indicative timeline for evaluation and grant agreementdescribed in Annex F of the Work Programme General Annexes.6. Legal and financial set-up of the grantsEligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.described in Annex G of the Work Programme General Annexes.Specific conditions described in the specific topic of the Work Programme Application and evaluation forms and model grant agreement (MGA): Application form templatesPlease use the application form that you will find in the Submission System. You can find examples of standard application forms in the Reference Documents page.Evaluation form templates — will be used with the necessary adaptationsStandard evaluation form (HE RIA, IA) GuidanceHE Programme Guide Model Grant Agreements (MGA)Lump Sum MGA Call-specific instructions Detailed budget table (HE LS) Information on clinical studies (HE) Guidance: "Lump sums - what do I need to know?"Additional documents: HE Main Work Programme 2026-2027 – 1. General Introducti
Ar šis kvietimas tinka jūsų organizacijai?
Nariams — automatinis tinkamumo vertinimas pagal jūsų profilį, raktažodžių paieška, filtrai, stebėjimo sąrašas ir pranešimai apie naujus panašius kvietimus.